Medtech venture funding hits new heights
Private device makers enjoy the biggest quarter for four years – and the average deal is larger than ever.
Google gears up to launch its first medical device
But with Derm Assist available free, how will the company make money?
Cognito’s Alzheimer’s brainwave
Gamma frequency neuromodulation is the key to treating dementia, according to the MIT spinout.
Onduo takes its time
The Verily subsidiary has the luxury of patient backers. But hungrier rivals could steal a march.
Philips spends nearly $3bn to integrate Biotelemetry
The deal is a late entrant into 2020's top five mergers and acquisitions.
Prescription apps take off during lockdown
Digital therapeutics are going from strength to strength during the pandemic.
Can Omada do a Livongo?
Omada is better funded than its digital health rival Livongo, but can it achieve a similar valuation?
